Background illustration for clinical trials search

Paid Clinical Trials Boston

Discover 3,070 paid clinical trials in Boston, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Improving Outcomes of Older Adults Undergoing Ostomy Surgery

for
Ostomy - Ileostomy or Colostomy
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07424586

Early_phase1, Recruiting

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

for
Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer,
Location: Boston MA, New York NY, Houston TX, San Antonio TX,
Sponsor: Monopteros Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04859777

Phase1, Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Boston MA, South Portland ME, New Haven CT,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06064877

Phase3, Recruiting

VE416 for Treatment of Food Allergy

for
Peanut Allergy
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 12 - 55

Code: NCT03936998

Phase1, Phase2, Recruiting

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

for
NSCLC
Location: Boston MA, Lebanon NH, New York NY, Fairfax VA,
Sponsor: Lung Cancer Mutation Consortium

Sex: All

Age: 0+

Code: NCT04712877

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy

for
PSP - Progressive Supranuclear Palsy, PD - Parkinson's Disease,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 55+

Code: NCT03330353

Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma,
Location: Boston MA, Fairfax VA, Pittsburgh PA, Dallas TX
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT04370587

Phase1, Phase2, Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for
Atrial Fibrillation
Location: Boston MA, Burlington MA, Providence RI, Scarborough ME,
Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase3, Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Boston MA, New Haven CT, The Bronx NY, New York NY,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase1, Phase2, Recruiting

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

for
Primary Myelofibrosis
Location: Boston MA, New York NY, Columbus OH, Ann Arbor MI,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06343805

Phase1, Recruiting

Patient Navigation to Improve Patient-Centered Cancer Care

for
Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT03226405

Recruiting

Prostate Cancer Genetic Risk Evaluation and Screening Study

for
Prostatic Neoplasm, Prostate Cancer, BRCA2 Mutation,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 35 - 70+

Code: NCT05129605

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

for
Coronary Artery Disease
Location: Boston MA, Valhalla NY, Englewood NJ, Flushing NY,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399705

Phase3, Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Boston MA, Providence RI, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase2, Recruiting

Primary Tumor Research and Outcomes Network

for
Spinal Column Tumor
Location: Boston MA, Providence RI, New York NY, Baltimore MD,
Sponsor: AO Innovation Translation Center

Sex: All

Age: 0+

Code: NCT02790983

Recruiting

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

for
Sarcoma
Location: Boston MA, Pittsburgh PA, Jacksonville FL, Seattle WA,
Sponsor: CBA Research

Sex: All

Age: 18+

Code: NCT03002805

Phase1, Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

for
Obstructive Hypertrophic Cardiomyopathy
Location: Boston MA, Valhalla NY, Roslyn NY, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05489705

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Boston MA, East Providence RI, Portsmouth NH,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase2, Phase3, Recruiting

Advanced Imaging for Pulmonary Fibrosis

for
Pulmonary Fibrosis
Location: Boston MA
Sponsor: Peter Caravan

Sex: All

Age: 18 - 70+

Code: NCT06532071

Phase2, Recruiting

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

for
Recurrent Pericarditis
Location: Boston MA, Burlington VT, New York NY, Montreal,
Sponsor: Cardiol Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06708299

Phase3, Recruiting

With its world-renowned healthcare network and prestigious medical research institutions, Boston is a premier destination for a wide range of clinical trials. Major centers such as Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and the Dana-Farber Cancer Institute lead groundbreaking studies across various medical fields. These institutions are at the forefront of innovation, making Boston a hub for cutting-edge clinical research.

Why choose Boston for clinical trials?

Boston stands out as a leader in healthcare and life science, and has become an important destination for participants taking part in clinical trials. With world-class medical institutions and a diverse patient population, researchers can deliver more reliable and relevant results.

The city is also home to an innovative research ecosystem, strengthened by close collaborations between hospitals, universities, and biotech companies, making it a hub for cutting-edge clinical studies.

Common conditions studied in Boston

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Boston